Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis S. Chatzipanagiotou, J.N.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis Nancy Simonney, Jean Michel Molina, Mathieu Molimard, Eric Oksenhendler,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

Herpes zoster in non-hospitalized children

Cross-reaction between Yersinia outer membrane proteins and anti-Borreli antibodies in sera of patients with Lyme disease E. Golkocheva-Markova, I. Christova,

E. Kunter, K. Cerrahoglu, A. Ilvan, T. Isitmangil, O. Turken, O

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Immunoenzymatic dot-blot test for the diagnosis of enteric fever caused by Salmonella typhi in an endemic area Nora Cardona-Castro, Piedad Agudelo-Flórez

R. Cantón Clinical Microbiology and Infection

Link between intracellular pathogens and cardiovascular diseases

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

Prevalence of Toscana virus antibodies in residents of Croatia

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Isospora belli infection in a patient with non-Hodgkin's lymphoma

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Retrospective study of CMV retinitis in patients with AIDS

Laboratory diagnosis and biosafety issues of biological warfare agents

Uncommon opportunistic fungi: new nosocomial threats

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

A case of pleurisy associated with antibodies to Rickettsia conorii

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

The practice of travel medicine in Europe

Pathogenesis of catheter-related infections: lessons for new designs

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

A.P. Underwood, J. Green Clinical Microbiology and Infection

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.

A. Norberg, C.E. Nord, B. Evengård Clinical Microbiology and Infection

S. Alexiou-Daniel, A. Stylianakis, A. Papoutsi, I. Zorbas, A. Papa, A

C.P. Kelly Clinical Microbiology and Infection

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Clinical microbiological case: facial inflammation in a child with a subnormal serum concentration of IgG2 I. Paraskakis, G. Stamos, C.S. Stavrinadis,

Abstracts Clinical Microbiology and Infection

Plague in the genomic area

Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection M. Croze, O. Dauwalder, O. Dumitrescu,

Serum ferritin levels in West Nile encephalitis

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

D. Baud, C. Kebbi, J.-P. Külling, G. Greub

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Typing of Clostridium difficile

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis S. Chatzipanagiotou, J.N. Legakis, F. Boufidou, V. Petroyianni, C. Nicolaou Clinical Microbiology and Infection Volume 7, Issue 3, Pages 138-143 (March 2001) DOI: 10.1046/j.1469-0691.2001.00221.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Western blot for class-specific anti-Yop antibodies. Lanes 1–5: anti-Yop IgG. Lane 1: control equivocal. Lane 2: control positive. Lane 3: patient's serum equivocal. Lanes 4 and 5: patients' sera positive. Lanes 6–10: anti-Yop IgA. Lanes 6 and 7: positive controls. Lanes 8–10: patients' sera positive. Clinical Microbiology and Infection 2001 7, 138-143DOI: (10.1046/j.1469-0691.2001.00221.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions